{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:50:12Z","timestamp":1793170212096,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaophthalmol.2020.5730","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T16:44:25Z","timestamp":1608741865000},"page":"182","source":"Crossref","is-referenced-by-count":157,"title":["Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease"],"prefix":"10.1001","volume":"139","author":[{"given":"Cason B.","family":"Robbins","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atalie C.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjit K.","family":"Bhullar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Yan","family":"Koo","sequence":"additional","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[{"name":"National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Soundararajan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce W.","family":"Polascik","sequence":"additional","affiliation":[{"name":"Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton L.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilraj S.","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Fekrat","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"eoi200102r1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein.","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"eoi200102r2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"eoi200102r3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management.","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"11","key":"eoi200102r4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"eoi200102r5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/bpa.2013.23.issue-2","article-title":"Vascular degeneration in Parkinson\u2019s disease.","volume":"23","author":"Guan","year":"2013","journal-title":"Brain Pathol"},{"issue":"18","key":"eoi200102r6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1212\/WNL.0000000000002082","article-title":"Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.","volume":"85","author":"van der Holst","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"eoi200102r7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7150\/ijms.18025","article-title":"Parkinson\u2019s disease might increase the risk of cerebral ischemic lesions.","volume":"14","author":"Song","year":"2017","journal-title":"Int J Med Sci"},{"issue":"12","key":"eoi200102r8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"5 Movement Disorders","key":"eoi200102r9","first-page":"1189","article-title":"Parkinsonian syndromes.","volume":"19","author":"Williams","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"eoi200102r10","first-page":"29","article-title":"The impact of DaTscan on the diagnosis and management of movement disorders: a retrospective study.","volume":"2","author":"Seifert","year":"2013","journal-title":"Am J Neurodegener Dis"},{"issue":"1","key":"eoi200102r11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain\u2014from eye research to CNS disorders.","volume":"9","author":"London","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"eoi200102r12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ophtha.2015.07.026","article-title":"In vivo characterization of retinal microvascular network in multiple sclerosis.","volume":"123","author":"Jiang","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi200102r13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.oret.2019.02.002","article-title":"Retinal microvascular and neurodegenerative changes in Alzheimer\u2019s disease and mild cognitive impairment compared with control participants.","volume":"3","author":"Yoon","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"13","key":"eoi200102r14","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1167\/iovs.16-20025","article-title":"Visual contrast sensitivity in early-stage Parkinson\u2019s disease.","volume":"57","author":"Ming","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi200102r15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fneur.2017.00162","article-title":"Retinal ganglion cells and circadian rhythms in Alzheimer\u2019s disease, Parkinson\u2019s disease, and beyond.","volume":"8","author":"La Morgia","year":"2017","journal-title":"Front Neurol"},{"issue":"1","key":"eoi200102r16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/EJO.2010.1318","article-title":"Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.","volume":"21","author":"Moschos","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"eoi200102r17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1167\/iovs.13-13062","article-title":"Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.","volume":"55","author":"Garcia-Martin","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi200102r18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","article-title":"Phosphorylated a-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity.","volume":"33","author":"Ortu\u00f1o-Lizar\u00e1n","year":"2018","journal-title":"Mov Disord"},{"issue":"5035","key":"eoi200102r19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography.","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"issue":"1","key":"eoi200102r20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085718","article-title":"Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis.","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"eoi200102r21","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ophtha.2012.05.003","article-title":"Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson\u2019s disease.","volume":"119","author":"Garcia-Martin","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi200102r22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2013.4","article-title":"Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients.","volume":"27","author":"Satue","year":"2013","journal-title":"Eye (Lond)"},{"issue":"1","key":"eoi200102r23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/02713683.2017.1370116","article-title":"Retinal and choroidal changes in patients with Parkinson\u2019s disease detected by swept-source optical coherence tomography.","volume":"43","author":"Satue","year":"2018","journal-title":"Curr Eye Res"},{"issue":"1","key":"eoi200102r24","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1111\/aos.2016.94.issue-1","article-title":"The choroid and lamina cribrosa is affected in patients with Parkinson\u2019s disease: enhanced depth imaging optical coherence tomography study.","volume":"94","author":"Eraslan","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"eoi200102r25","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study.","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"eoi200102r26","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1038\/s41598-019-42534-x","article-title":"Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study.","volume":"9","author":"McGrory","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"eoi200102r27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jamaophthalmol.2014.3616","article-title":"Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography.","volume":"133","author":"Spaide","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi200102r28","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1167\/iovs.17-23230","article-title":"Retinal microvascular impairment in the early stages of Parkinson\u2019s disease.","volume":"59","author":"Kwapong","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi200102r29","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1097\/IAE.0000000000002641","article-title":"Characterization by fractal dimension analysis of the retinal capillary network in Parkinson disease.","volume":"40","author":"Shi","year":"2020","journal-title":"Retina"},{"issue":"20","key":"eoi200102r30","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"eoi200102r31","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.v33.10","article-title":"Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"33","author":"Postuma","year":"2018","journal-title":"Mov Disord"},{"key":"eoi200102r32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/issn.0250-3751","article-title":"ZEISS angioplex spectral domain optical coherence tomography angiography: technical aspects.","volume":"56","author":"Rosenfeld","year":"2016","journal-title":"Dev Ophthalmol"},{"issue":"12","key":"eoi200102r33","first-page":"1698","article-title":"Relation between superficial capillaries and foveal structures in the human retina.","volume":"27","author":"Iwasaki","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"eoi200102r34","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1167\/iovs.12-10414","article-title":"Determinants of ganglion cell-inner plexiform layer thickness measured by high-definition optical coherence tomography.","volume":"53","author":"Koh","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi200102r35","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/OPTH","article-title":"Alteration of retinal layers in healthy subjects over 60 years of age until nonagenarians.","volume":"11","author":"Altay","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"eoi200102r36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/tvst.8.3.34","article-title":"Determinants of macular layers and optic disc characteristics on SD-OCT: the Rhineland study.","volume":"8","author":"Mauschitz","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"eoi200102r37","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/bjo.2006.113399","article-title":"Effects of dopamine on retinal and choroidal blood flow parameters in humans.","volume":"91","author":"Huemer","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"eoi200102r38","doi-asserted-by":"publisher","first-page":"34936","DOI":"10.1038\/srep34936","article-title":"The effect of topical atropine on the choroidal thickness of healthy children.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"eoi200102r39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid.","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2774377\/jamaophthalmology_robbins_2020_oi_200102_1613153474.98902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T15:41:50Z","timestamp":1613835710000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2774377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5730","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}